38 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00043 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 12.9% inhibition at 10-6 M |
| dbacp00044 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 16.5% inhibition at 10-5 M |
| dbacp00045 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 28.1% inhibition at 10-4 M |
| dbacp00046 | Enkephalins7 analogue-8 | YA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 58.2% inhibition at 10-3 M |
| dbacp00067 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.5% inhibition at 10-6 M |
| dbacp00068 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 21.9% inhibition at 10-5 M |
| dbacp00069 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 11.8% inhibition at 10-4 M |
| dbacp00070 | Enkephalins7 analogue-9 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 17.9% inhibition at 10-3 M |
| dbacp00094 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.7% inhibition at 10-6 M |
| dbacp00095 | Enkephalins7 analogue-10 | YSA* | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 10.0% inhibition at 10-5 M |
| dbacp00141 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.6% inhibition at 10-6 M |
| dbacp00142 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 20.4% inhibition at 10-5 M |
| dbacp00143 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 14.4% inhibition at 10-4 M |
| dbacp00144 | Enkephalins7 analogue-15 | YSA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 23.4% inhibition at 10-3 M |
| dbacp00174 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 17.0% inhibition at 10-6 M |
| dbacp00175 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.5% inhibition at 10-5 M |
| dbacp00176 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.5% inhibition at 10-4 M |
| dbacp00177 | Enkephalins7 analogue-16 | YRA*G | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 25.3% inhibition at 10-3 M |
| dbacp00208 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 12.2% inhibition at 10-6 M |
| dbacp00209 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 15.5% inhibition at 10-5 M |
| dbacp00210 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 24.7% inhibition at 10-4 M |
| dbacp00211 | Enkephalins7 analogue-17 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 29.0% inhibition at 10-3 M |
| dbacp00242 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 26.4% inhibition at 10-6 M |
| dbacp00243 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 13.1% inhibition at 10-5 M |
| dbacp00244 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 14.6% inhibition at 10-4 M |
| dbacp00245 | Enkephalins7 analogue-18 | YA*GFM | Synthetic Peptide | Apoptosis inducing | MTT/MTS assay | SW-620 | Colon cancer | 38.4% inhibition at 10-3 M |
| dbacp02044 | Buforin IIb | RAGLQFPVGRLLRRLLRRLLR | Histone H2A | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SW-620 | Colon cancer | IC50 : 12.7 µg/ml |
| dbacp02102 | Buforin Iib | RAGLQFPVGRLLRRLLRRLLR | Not found | Inducing apoptosis | MTT/MTS assay | SW-620 | Not specified | IC50 : 12.7 µg/ml |
| dbacp05092 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | SW-620 | Colorectal cancer | Not found |
| dbacp07086 | HB43 | FAKLLAKLAKKLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 10 ± 1 μM |
| dbacp07090 | HB43-mut2 | FAKLLAKLAKLLK | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 40 ± 3 μM |
| dbacp07094 | HB43-mut3 | FAKLLAKLARRLL | Synthetic | Motif-driven membrane insertion triggers cytotoxicity | AlamarBlue assay | SW-620 | Colon Cancer | IC50 = 9 ± 1 μM |
| dbacp07288 | P264-G274 | PARDVLNTTSG | Parasporin-2Aa1 | h-APN receptor–mediated apoptosis induction. | Sulforhodamine B assay | SW-620 | Colorectal Cancer | EC50 = 11.28 ± 0.52 µM |
| dbacp07290 | Loop1-PS2Aa | NNETYFNAVKP | Parasporin-2Aa1 | h-APN receptor–mediated apoptosis induction. | Sulforhodamine B assay | SW-620 | Colorectal Cancer | EC50 = 106.2 ± 1.67 µM |
| dbacp07292 | Loop2-PS2Aa | TYFNAVKPPITA | Parasporin-2Aa1 | h-APN receptor–mediated apoptosis induction. | Sulforhodamine B assay | SW-620 | Colorectal Cancer | EC50 = 15.95 ± 0.69 µM |
| dbacp07295 | A4W-GGN5 | FLGWLFKVASK | Gaegurin 5 | h-APN receptor–mediated apoptosis induction. | Sulforhodamine B assay | SW-620 | Colorectal Cancer | EC50 = 22.07 ± 1.63 µM |
| dbacp07948 | IL13Rα2 D1 peptide | GSETWKTIITKN | Synthetic | IL13Rα2 blockade inhibits cancer metastasis | MTT assay | SW-620 | Colorectal Cancer | inhibited IL13-stimulated cell adhesion |
| dbacp08062 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | SW-620 | Colorectal Cancer | EC50 = 64.61 ± 1.63 μM |